OSIMERTINIB

11393 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking OSIMERTINIB:

# Side effect Count
0 DEATH 4091
1 MALIGNANT NEOPLASM PROGRESSION 1506
2 DIARRHOEA 720
3 DRUG RESISTANCE 595
4 RASH 424
5 INTERSTITIAL LUNG DISEASE 386
6 DECREASED APPETITE 383
7 FATIGUE 364
8 DYSPNOEA 313
9 OFF LABEL USE 309
See all common reactions for OSIMERTINIB

OSIMERTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 GENE AMPLIFICATION 5 0.5000
1 EGFR GENE MUTATION 73 0.3106
2 ACQUIRED GENE MUTATION 236 0.2906
3 BRAF V600E MUTATION POSITIVE 6 0.2222
4 ERYTHEMA DYSCHROMICUM PERSTANS 6 0.1875
5 MALIGNANT TRANSFORMATION 45 0.1585
6 BRAF GENE MUTATION 9 0.1525
7 RET GENE MUTATION 3 0.1364
8 CITROBACTER BACTERAEMIA 2 0.1250
9 NON-SMALL CELL LUNG CANCER RECURRENT 11 0.1078
See all enriched reactions for OSIMERTINIB